Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,544,182
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
25,458,553
-
Shares change
-
+25,458,553
-
Total reported value, excl. options
-
$701,864,000
-
Value change
-
+$701,864,000
-
Number of buys
-
52
-
Price
-
$28.26
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q2 2020
52 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q2 2020.
Avidity Biosciences, Inc. - Common Stock (RNA) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,458,553 shares
of 149,544,182 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3,995,000 shares), FMR LLC (2,832,852 shares), Cormorant Asset Management, LP (2,514,547 shares), EcoR1 Capital, LLC (2,103,950 shares), PERCEPTIVE ADVISORS LLC (1,235,818 shares), Matrix Capital Management Company, LP (1,200,000 shares), BOXER CAPITAL, LLC (1,121,327 shares), PRICE T ROWE ASSOCIATES INC /MD/ (950,400 shares), Logos Global Management LP (926,454 shares), and VICTORY CAPITAL MANAGEMENT INC (890,780 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.